SS-31 Buy Now at the best price online. Choose Peptide Sciences, a company that specializes in the production and distribution of peptides, proteins, and amino acids for research purposes. Here are a few reasons why some researchers may choose Peptide Sciences:
Peptide Sciences is known for its commitment to providing high-quality products. They employ strict quality control measures to ensure the purity and integrity of their research chemicals. This includes employing analytical techniques such as mass spectrometry to verify the identity and composition of their products.
Peptide Sciences offers a wide range of research chemicals, including peptides, proteins, and amino acids. This variety allows researchers to find the specific compounds they need for their studies.
Reputation And Customer Reviews
Positive customer reviews and a good reputation in the research community can indicate a reliable supplier. It can be helpful to seek out feedback from other researchers who have used Peptide Sciences’ products to assess their experiences and satisfaction.
Secure Ordering And Packaging
Peptide Sciences typically ensures secure online ordering systems and packaging methods to maintain the integrity of the products during shipping. This helps to minimize the risk of contamination or degradation during transit.
Compliance With Regulations
It’s important to choose a supplier that complies with relevant regulations and guidelines for research chemicals. Peptide Sciences claims to adhere to these regulations, including the handling and distribution of their products in accordance with applicable laws.
It is crucial for researchers to conduct your own research and carefully evaluate any supplier before making a purchase. Consider factors such as the specific needs of your research, pricing, shipping options. Along, with the reputation of the company within the scientific community.
Introduction To SS-31 Peptide
The SS-31 peptide, is also known as Elamipretide or Bendavia. It is a synthetic peptide that selectively targets the inner mitochondrial membrane. It has shown promise in preclinical studies for various diseases and conditions. This article provides an overview of what the SS-31 peptide is, how it works, and the potential benefits it offers in treating multiple disorders.
What Is SS-31 Peptide?
SS-31 peptide is a synthetic peptide that can penetrate cells and explicitly targets the inner mitochondrial membrane. Initially developed to address mitochondrial dysfunction-related diseases, such as neurodegenerative disorders, heart failure, and metabolic diseases, it has a unique amino acid sequence (D-Arg-2′,6′-dimethylTyr-Lys-Phe-NH2). This sequence allows it to bind to cardiolipin, a phospholipid found predominantly in the inner mitochondrial membrane, protecting mitochondrial function from oxidative stress.
What Is The Mechanism Of Action Of SS-31?
The primary mechanism of action of the SS-31 peptide involves its interaction with cardiolipin. Cardiolipin plays a vital role in maintaining the structure and function of the mitochondrial inner membrane. It helps stabilize mitochondrial membrane protein complexes, regulate membrane curvature, and preserve mitochondrial structure.
SS-31 peptide interacts with cardiolipin to influence membrane curvature and prevent damage caused by peroxidation, which can lead to mitochondrial dysfunction. It can enhance electron transport chain complex coupling, reduce the production of reactive oxygen species (ROS), and safeguard cardiolipin from peroxidative damage. These actions contribute to improved mitochondrial function and reduced oxidative stress in cells.
Potential Benefits Of SS-31 Peptide
In preclinical studies focused on neurodegenerative diseases like Alzheimer’s and Parkinson’s, the SS-31 peptide has demonstrated promising results. These diseases are characterized by the accumulation of damaged mitochondria and increased oxidative stress, which can lead to neuronal cell death.
In cellular and animal models of Alzheimer’s disease, SS-31 peptide can enhance mitochondrial function, reduce ROS production, and protect against toxicity induced by amyloid-beta. Models of Parkinson’s disease has shown the ability to improve mitochondrial bioenergetics, reduce oxidative stress, and promote neuronal survival.
SS-31 peptide has exhibited the potential to improve mitochondrial function in heart failure models. Heart failure can impair energy production and heighten oxidative stress in the heart. SS-31 peptide has shown signs of protecting the heart from ischemia-reperfusion injury, a significant cause of heart failure, by reducing ROS production, preserving mitochondrial function, and preventing cardiomyocyte death.
Furthermore, in animal models of dilated cardiomyopathy and ataxia syndrome (DCMA), a rare mitochondrial disease associated with heart failure. The SS-31 peptide can enhance cardiac function. In these models, it can reverse mitochondrial fragmentation, reduce ROS production, and improve cardiac function.
SS-31 peptide has shown potential in treating metabolic diseases like type 2 diabetes and obesity. In diabetic animal models, it has been observed to enhance mitochondrial function in skeletal muscle, liver, and heart tissues. It also reduces oxidative stress, improves glucose tolerance, and enhances insulin sensitivity. In obese animals, SS-31 peptide has been shown to increase fatty acid oxidation and energy expenditure, leading to weight reduction and improved metabolic health.
Other Diseases And Conditions
SS-31 peptide has demonstrated promise in addressing other diseases and conditions associated with mitochondrial dysfunction, such as:
- Friedreich’s ataxia: In cellular models of Friedreich’s ataxia, the SS-31 peptide has been reported to upregulate frataxin expression, improve mitochondrial function, and protect against oxidative stress. Friedreich’s ataxia is a neurodegenerative disease associated with cardiomyopathy.
- Acute kidney injury: Animal models have shown that SS-31 peptide can protect against ischemia-reperfusion-induced kidney injury. It achieves this by reducing ROS production and preserving mitochondrial function.
- Age-related macular degeneration: SS-31 peptide has been found to protect retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. It suggests potential benefits in age-related macular degeneration.
SS-31 Peptide Dosage
The optimal dose of SS-31 peptide for human use has yet to be established, as clinical trials are ongoing to evaluate its safety and effectiveness in various diseases. In preclinical studies, doses ranging from 1 to 10 mg/kg/day have been administered, depending on the specific model and disease. The peptide is typically delivered intravenously or subcutaneously, with treatment durations varying from a few days to several weeks.
What Are The Benefits Of SS-31 Peptide?
SS-31 peptide shows promise as a therapeutic agent for various diseases and conditions associated with mitochondrial dysfunction and oxidative stress. Targeting cardiolipin in the inner mitochondrial membrane offers potential benefits in treating neurodegenerative diseases, heart failure, metabolic diseases, and other conditions related to mitochondrial dysfunction.
However, it is essential to note that most studies have been preclinical, utilizing cellular and animal models. More research, including human clinical trials, is necessary to determine the safety, efficacy, and optimal dosage of SS-31 peptides for treating different human diseases and conditions.